Keytruda
我们是谁
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
在晚期癌症患者中测试与 Ziv-aflibercept 联用的 PD-1 抗体 MK3475
Pembrolizumab 在 MMR 精通的转移性结直肠癌中的药理作用触发高突变状态
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
Pembrolizumab和Nintedanib试验
CGX1321 在晚期实体瘤受试者中的应用,以及 CGX1321 与 Pembrolizumab 或 Encorafenib + 西妥昔单抗在晚期消化道肿瘤受试者中的应用(主题演讲 596)
Pembrolizumab 与培美曲塞和奥沙利铂联合治疗化疗难治性转移性结直肠癌患者的研究